抗老化薬の世界市場レポート 2025年

抗老化薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.4％で848億6,000万米ドルに成長します。予測期間の成長は、精密医療へのアプローチ、老人溶解薬の出現、研究における共同研究・提携、老化治療薬の規制経路、アンチエイジング介入を採用する消費者の増加などに起因すると考えられます。予測期間の主な動向には、標的療法と個別化医療、細胞老化のための老人溶解薬、遺伝子治療とクリスプルー技術、ミトコンドリアの健康への注目、長寿のためのマイクロバイオーム調節などが含まれます。

抗老化薬市場の成長は、高齢化人口の増加によって促進されると予想されます。この人口動態の変化は、社会における他の年齢層と比較して、60歳以上の高齢者の割合が増加していることを浮き彫りにしています。このシフトは、ヘルスケアの進歩による寿命の延長、出生率の低下、社会・経済構造の変革の結果です。抗老化薬は、若々しい特徴を持つ個人の健康寿命を延ばすことを目的としています。例えば、2022年10月の世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上になり、2020年までに10億人だった高齢者が14億人に増加するという予測が示されています。また、Eurostatのデータベースによると、65歳以上の高齢者は人口の21.1％を占め、前年から0.3％、10年前から3.1％増加しました。したがって、高齢化人口の急増が抗老化薬市場の成長を大きく後押ししています。

抗老化薬市場の拡大は、人々の可処分所得の増加によって牽引されると予想されます。この可処分所得の増加は、一般的に経済の改善と相関し、賃金や給与の上昇、ヘルスケア支出の増加につながります。可処分所得は、抗老化薬の使用量に影響を与える極めて重要な役割を果たしています。このような利用しやすさが、若々しさを保ち、加齢に関連した悩みに取り組むことを目的とした、利用率の増加に寄与しています。たとえば、2023年8月の経済分析局のデータでは、可処分個人所得は73億米ドルの増加（0.1％未満）、個人消費支出（PCE）は1,446億米ドルの増加（0.8％）となっています。このように、人々の可処分所得の増加は、抗老化薬市場の成長を大きく後押しします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗老化薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の抗老化薬市場：成長率分析
• 世界の抗老化薬市場の実績：規模と成長, 2019-2024
• 世界の抗老化薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗老化薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗老化薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 美容液
• クリーム
• ジェル
• その他の製品
• 世界の抗老化薬市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン療法
• 抗酸化物質
• 酵素
• 幹細胞
• 世界の抗老化薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射可能
• オーラル
• 話題
• 世界の抗老化薬市場成分別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レチノイド
• ヒアルロン酸
• アルファヒドロキシ酸
• その他の成分
• 世界の抗老化薬市場薬剤用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚と髪
• 骨格と筋肉
• 加齢に伴う障害
• その他の用途
• 世界の抗老化薬市場、血清の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンチエイジングビタミンC美容液
• レチノール美容液
• ペプチド美容液
• 世界の抗老化薬市場、クリームの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 保湿アンチエイジングクリーム
• ナイトクリーム
• アイクリーム
• 世界の抗老化薬市場、ゲルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 保湿アンチエイジングジェル
• 引き締めジェル
• 角質除去ジェル
• 世界の抗老化薬市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マスク
• サプリメント
• 治療

第7章 地域別・国別分析

• 世界の抗老化薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗老化薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗老化薬市場：競合情勢
• 抗老化薬市場：企業プロファイル
  • L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Elysium Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Estee Lauder Companies Inc.
• AbbVie Inc.
• La Roche-Posay
• Nu Skin Enterprises Inc.
• Dermafix Biotech Private Limited
• The Procter & Gamble Company
• Johnson & Johnson Services Inc.
• Sun Pharmaceutical Industries Ltd.
• BioTime Inc.
• PT. Daewoong Pharmaceutical Co. Ltd.
• Allergan plc
• MMJ PhytoTech Limited
• Revitacare
• SciVision Biotech
• Canbex Therapeutics Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗老化薬市場2029：新たな機会を提供する国
• 抗老化薬市場2029：新たな機会を提供するセグメント
• 抗老化薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anti-aging drugs are a category of medications or supplements designed to decelerate or potentially reverse the aging process, addressing the underlying causes of aging and aiming to alleviate age-related illnesses.

The primary types of anti-aging drugs include serums, creams, gels, and other formulations. Serums are clear, yellowish liquids that remain after blood clotting and removal of blood cells. These drugs fall into various classes, including hormonal therapy, antioxidants, enzymes, stem cells, and others, available in forms such as injectables, oral medications, and topical applications. Various ingredients such as retinoid, hyaluronic acid, alpha hydroxy acid, among others, are applied to the skin and hair, targeting skeletal and muscle health, age-related disorders, and other aspects of the aging process.

The anti-aging drugs market research report is one of a series of new reports from The Business Research Company that provides anti-aging drugs market statistics, including anti-aging drugs industry global market size, regional shares, competitors with a anti-aging drugs market share, detailed anti-aging drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-aging drugs industry. This anti-aging drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-aging drugs market size has grown strongly in recent years. It will grow from$57.18 billion in 2024 to $61.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the rise in chronic diseases associated with aging, increasing awareness of aging-related health issues, regulatory support for aging research, and consumer focus on wellness and longevity

The anti-aging drugs market size is expected to see strong growth in the next few years. It will grow to $84.86 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of senolytic drugs, collaborations and partnerships in research, regulatory pathways for aging therapeutics, increased consumer adoption of anti-aging interventions. Major trends in the forecast period include targeted therapies and personalized medicine, senolytic drugs for cellular senescence, gene therapy and Crispr technologies, focus on mitochondrial health, microbiome modulation for longevity.

The growth of the anti-aging drugs market is anticipated to be fueled by the increasing aging population. This demographic shift highlights a rising proportion of individuals aged 60 years or older compared to other age cohorts within societies. This shift is a consequence of advancements in healthcare, resulting in extended lifespans, declining fertility rates, and transformations in social and economic structures. Anti-aging medications are aimed at extending the healthy lifespan of individuals who display youthful characteristics. For instance, according to the World Health Organization in October 2022, projections indicate that by 2030, one in every six individuals globally will be over 60 years old, marking an increase from 1 billion to 1.4 billion elderly individuals by 2020. Additionally, as per the Eurostat database, individuals aged 65 and above constituted 21.1% of the population, witnessing a 0.3% rise from the previous year and a 3.1% increase from a decade earlier. Hence, the surge in the aging population significantly propels the growth of the anti-aging drugs market.

The expansion of the anti-aging drugs market is expected to be driven by an increase in people's disposable income. This rise in disposable income typically correlates with economic improvements, leading to elevated wages, salaries, and heightened healthcare expenditures. Disposable income plays a pivotal role in influencing the usage of anti-aging drugs, as individuals with higher income levels often possess better accessibility and affordability for these treatments. This accessibility contributes to increased utilization, aiming to preserve a youthful appearance and tackle age-related concerns. For instance, data from the Bureau of Economic Analysis in August 2023 revealed a $7.3 billion rise (less than 0.1%) in disposable personal income and a $144.6 billion increase (0.8%) in personal consumption expenditures (PCE). Thus, the upsurge in people's disposable income significantly drives the growth of the anti-aging drugs market.

Embracing product innovation stands as a significant trend gaining traction within the anti-aging drugs market. Companies within this sector are actively integrating innovative products to fortify their market presence. For example, in April 2023, SkinCeuticals, a US-based leader in advanced skincare, unveiled the corrective cream A.G.E Interrupter Advanced. This product amplifies collagen matrix integrity, featuring a formulation infused with wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E Interrupter). A.G.E. Interrupter Advanced sets itself apart from standard anti-aging products by addressing all stages of the glycation process, rectifying existing signs of aging, and safeguarding against new and recurring damage induced by A.G.E. formation.

Leading companies in the anti-aging drug market are channeling efforts towards the development of cutting-edge skincare solutions aimed at combatting age-related conditions, promoting longevity, and enhancing overall health and well-being. Advanced skincare solutions for anti-aging encompass a spectrum of innovative products and treatments meticulously designed to target and diminish aging signs. These solutions elevate skin health and appearance through the utilization of state-of-the-art technologies and formulations. For instance, in August 2022, NutriGlow Cosmetics Pvt. Ltd., an India-based beauty product provider, introduced a limited-edition line of anti-aging skincare products on their platform. This range includes items such as NutriGlow Advanced Organics Anti Pigmentation Serum, Anti Pigmentation Night Cream, Age Repair Tightening Serum, Age Repair Tightening Day Cream, Vitamin C Skin Lightening Serum, and Vitamin C Skin Lightening Night Cream. These dermatologically-tested anti-aging products are infused with Vitamin C and Hyaluronic Acid, addressing various skin concerns such as dark spots, fine lines, hyperpigmentation, discoloration, and uneven skin tone for consumers.

In August 2024, L'Oreal, a U.S.-based manufacturer of beauty and hair products, acquired Galderma S.A. for an undisclosed amount. This acquisition strengthens L'Oreal's presence in the rapidly expanding injectables segment by leveraging Galderma's expertise in dermatology and aesthetics. This strategic move enables L'Oreal to diversify its product offerings and capitalize on the growing consumer demand for non-invasive beauty treatments. Galderma S.A. is a U.S.-based pharmaceutical company focused on dermatological treatments and skin care products.

Major companies operating in the anti-aging drugs market include L'Oreal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estee Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro

North America was the largest region in the anti-aging drugs market in 2024. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the anti-aging drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The anti-aging drugs market consists of sales of dermal fillers, botulinum toxin, anti-wrinkle products, and anti-stretch mark products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Aging Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-aging drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-aging drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-aging drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Serums; Creams; Gels; Other Products
• 2) By Drug Class: Hormonal Therapy; Antioxidants; Enzymes; Stem Cells
• 3) By Type: Injectable; Oral; Topical
• 4) By Ingredient: Retinoid; Hyaluronic Acid; Alpha Hydroxy Acid; Other Ingredients
• 5) By Drug Application: Skin And Hair; Skeletal And Muscles; Age Related Disorders; Other Applications
• Subsegments:
• 1) By Serums: Anti-Aging Vitamin C Serums; Retinol Serums; Peptide Serums
• 2) By Creams: Moisturizing Anti-Aging Creams; Night Creams; Eye Creams
• 3) By Gels: Hydrating Anti-Aging Gels; Firming Gels; Exfoliating Gels
• 4) By Other Products: Masks; Supplements; Treatments
• Companies Mentioned: L'Oreal S.A.; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Sanofi S.A.; Elysium Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Aging Drugs Market Characteristics

3. Anti-Aging Drugs Market Trends And Strategies

4. Anti-Aging Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Anti-Aging Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Aging Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Aging Drugs Market Growth Rate Analysis
• 5.4. Global Anti-Aging Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Aging Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Aging Drugs Total Addressable Market (TAM)

6. Anti-Aging Drugs Market Segmentation

• 6.1. Global Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serums
• Creams
• Gels
• Other Products
• 6.2. Global Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Therapy
• Antioxidants
• Enzymes
• Stem Cells
• 6.3. Global Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Topical
• 6.4. Global Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoid
• Hyaluronic Acid
• Alpha Hydroxy Acid
• Other Ingredients
• 6.5. Global Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin And Hair
• Skeletal And Muscles
• Age Related Disorders
• Other Applications
• 6.6. Global Anti-Aging Drugs Market, Sub-Segmentation Of Serums, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Aging Vitamin C Serums
• Retinol Serums
• Peptide Serums
• 6.7. Global Anti-Aging Drugs Market, Sub-Segmentation Of Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Moisturizing Anti-Aging Creams
• Night Creams
• Eye Creams
• 6.8. Global Anti-Aging Drugs Market, Sub-Segmentation Of Gels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrating Anti-Aging Gels
• Firming Gels
• Exfoliating Gels
• 6.9. Global Anti-Aging Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Masks
• Supplements
• Treatments

7. Anti-Aging Drugs Market Regional And Country Analysis

• 7.1. Global Anti-Aging Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Aging Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Aging Drugs Market

• 8.1. Asia-Pacific Anti-Aging Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Aging Drugs Market

• 9.1. China Anti-Aging Drugs Market Overview
• 9.2. China Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Aging Drugs Market

• 10.1. India Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Aging Drugs Market

• 11.1. Japan Anti-Aging Drugs Market Overview
• 11.2. Japan Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Aging Drugs Market

• 12.1. Australia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Aging Drugs Market

• 13.1. Indonesia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Aging Drugs Market

• 14.1. South Korea Anti-Aging Drugs Market Overview
• 14.2. South Korea Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Aging Drugs Market

• 15.1. Western Europe Anti-Aging Drugs Market Overview
• 15.2. Western Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Aging Drugs Market

• 16.1. UK Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Aging Drugs Market

• 17.1. Germany Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Aging Drugs Market

• 18.1. France Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Aging Drugs Market

• 19.1. Italy Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Aging Drugs Market

• 20.1. Spain Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Aging Drugs Market

• 21.1. Eastern Europe Anti-Aging Drugs Market Overview
• 21.2. Eastern Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Aging Drugs Market

• 22.1. Russia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Aging Drugs Market

• 23.1. North America Anti-Aging Drugs Market Overview
• 23.2. North America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Aging Drugs Market

• 24.1. USA Anti-Aging Drugs Market Overview
• 24.2. USA Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Aging Drugs Market

• 25.1. Canada Anti-Aging Drugs Market Overview
• 25.2. Canada Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Aging Drugs Market

• 26.1. South America Anti-Aging Drugs Market Overview
• 26.2. South America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Aging Drugs Market

• 27.1. Brazil Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Aging Drugs Market

• 28.1. Middle East Anti-Aging Drugs Market Overview
• 28.2. Middle East Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Aging Drugs Market

• 29.1. Africa Anti-Aging Drugs Market Overview
• 29.2. Africa Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Aging Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anti-Aging Drugs Market Competitive Landscape
• 30.2. Anti-Aging Drugs Market Company Profiles
  • 30.2.1. L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elysium Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Aging Drugs Market Other Major And Innovative Companies

• 31.1. Estee Lauder Companies Inc.
• 31.2. AbbVie Inc.
• 31.3. La Roche-Posay
• 31.4. Nu Skin Enterprises Inc.
• 31.5. Dermafix Biotech Private Limited
• 31.6. The Procter & Gamble Company
• 31.7. Johnson & Johnson Services Inc.
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. BioTime Inc.
• 31.10. PT. Daewoong Pharmaceutical Co. Ltd.
• 31.11. Allergan plc
• 31.12. MMJ PhytoTech Limited
• 31.13. Revitacare
• 31.14. SciVision Biotech
• 31.15. Canbex Therapeutics Ltd.

32. Global Anti-Aging Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Aging Drugs Market

34. Recent Developments In The Anti-Aging Drugs Market

35. Anti-Aging Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Aging Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Aging Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Aging Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer